Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Werewolf Therapeutics (HOWL) Equity Ratio (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Equity Ratio for 5 consecutive years, with 0.36 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 38.18% to 0.36 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.36 through Dec 2025, down 38.18% year-over-year, with the annual reading at 0.36 for FY2025, 38.18% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.36 at Werewolf Therapeutics, down from 0.37 in the prior quarter.
  • The five-year high for Equity Ratio was 0.95 in Q2 2021, with the low at 1.72 in Q1 2021.
  • Average Equity Ratio over 5 years is 0.55, with a median of 0.64 recorded in 2023.
  • The sharpest move saw Equity Ratio soared 149.22% in 2022, then crashed 41.73% in 2025.
  • Over 5 years, Equity Ratio stood at 0.85 in 2021, then dropped by 10.43% to 0.76 in 2022, then decreased by 16.56% to 0.64 in 2023, then decreased by 9.24% to 0.58 in 2024, then tumbled by 38.18% to 0.36 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.36, 0.37, and 0.45 for Q4 2025, Q3 2025, and Q2 2025 respectively.